Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$3.45 0.05 (1.43%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 196.93(M)
Last Volume: 97,895 Avg Vol: 97,622
52 Week Range: $1.32 - $4.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    : 4.5
Insider 6 Months    : 5.2
Insider 3/6 Months : 9.9
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 3,500 4,000 5,598 32,898
Total Buy Value $10,840 $11,733 $14,587 $57,671
Total People Bought 2 3 3 5
Total Buy Transactions 2 3 4 11
Total Shares Sold 25,000 25,000 25,000 45,000
Total Sell Value $76,500 $76,500 $76,500 $118,240
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 4
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 516
  Page 7 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Uihlein Richard E Director   –       •       •   2019-05-31 4 B $4.28 $32,999 I/I 7,710 27,710 2.25     -
   Uihlein Richard E Director   –       •       •   2019-05-31 4 B $4.28 $19,999,995 D/D 4,672,896 7,801,385 3.92     -
   Uihlein Richard E Director   –       •       •   2019-05-31 4/A B $4.28 $32,999 I/I 7,710 27,710 2.25     -
   Uihlein Richard E Director   –       •       •   2019-05-31 4/A B $4.28 $19,999,995 D/D 4,672,896 7,801,385 3.92     -
   Lewis Joel Director   –       •      –    2019-05-31 4 B $4.28 $54,994 D/D 12,849 78,649 2.39     -
   Omenn Gilbert S Director   –       •      –    2019-05-31 4 B $4.28 $79,514 D/D 18,578 66,769 2.39     -
   Callicutt Jack W Chief Financial Officer   •       –      –    2019-05-31 4 B $4.28 $10,075 D/D 2,354 3,614 2.74     -
   Freeman Kevin D Director   –       •      –    2019-05-31 4 B $4.28 $6,103 D/D 1,426 23,469 2.39     -
   Freeman Kevin D Director   –       •      –    2019-05-31 4 B $4.28 $32,999 I/I 7,710 9,710 2.1     -
   Eldred Kary Director   –       •      –    2019-05-31 4 B $4.28 $12,981 D/D 3,033 44,415 2.39     -
   Uihlein Richard E Director   –       •       •   2019-05-29 4 OE $5.00 $2,500,000 D/D 500,000 3,128,489     -
   Uihlein Richard E Director   –       •       •   2019-05-29 4/A OE $5.00 $2,500,000 D/D 500,000 3,128,489     -
   Czirr James C Managing Member of GP   –       –      –    2019-05-03 4 D $0.00 $0 D/D (67,515) 6,441,786     -
   Uihlein Richard E Director   –       •       •   2019-04-09 4 B $4.82 $99,851 D/D 20,700 2,628,489 3.92     -
   Lewis Joel Director   –       •      –    2019-04-05 4 B $4.82 $3,214 D/D 667 65,800 2.31     -
   Uihlein Richard E Director   –       •       •   2019-04-05 4 B $4.81 $100,972 D/D 21,000 2,607,789 3.92     -
   Freeman Kevin D Director   –       •      –    2019-04-05 4 B $4.73 $2,365 I/I 500 2,000 2.02     -
   Rubin Marc Director   –       •      –    2019-02-22 4 AS $6.02 $5,175 D/D (859) 13,581     -
   Rubin Marc Director   –       •      –    2019-02-22 4 OE $2.39 $2,053 D/D 859 14,440     -
   Rubin Marc Director   –       •      –    2019-02-21 4 AS $6.00 $303,026 D/D (50,326) 13,581     -
   Rubin Marc Director   –       •      –    2019-02-21 4 OE $2.39 $103,549 D/D 43,326 56,907     -
   Freeman Kevin D Director   –       •      –    2019-02-08 4 B $4.29 $6,428 I/I 1,500 1,500 2.1     -
   Lewis Joel Director   –       •      –    2019-02-07 4 B $4.48 $4,484 D/D 1,000 65,133 2.31     -
   Amelio Gilbert F Director   –       •      –    2019-01-31 4 S $5.00 $65,235 D/D (13,047) 154,614     -
   Amelio Gilbert F Director   –       •      –    2019-01-30 4 S $5.00 $84,765 D/D (16,953) 167,661     -
  516 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us